Article
Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells
25 Apr 2017
Abstract excerpt
Abstract TET2 is a dioxygenase that catalyses multiple steps of 5-methylcytosine oxidation. Although TET2 mutations frequently occur in various types of haematological malignancies, the mechanism by which they increase risk for these cancers remains poorly understood. Here we show that Tet2−/− mice develop spontaneous myeloid, T- and B-cell malignancies after long latencies. Exome sequencing of Tet2−/− tumours...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.